Clinical Trials Logo

Abnormal Uterine Bleeding clinical trials

View clinical trials related to Abnormal Uterine Bleeding.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05474703 Active, not recruiting - Clinical trials for Abnormal Uterine Bleeding

Evaluation of the Effects of Levonorgestrel-releasing Intrauterine Device and Dydrogestreone on Quality of Life and Sexual Life in Patients With Abnormal Uterine Bleeding.

Start date: February 20, 2022
Phase:
Study type: Observational [Patient Registry]

This study was retrospectively collected from patients who were diagnosed with abnormal uterine bleeding and received oral dydrogesterone therapy for at least six months or who were administered an intrauterine device containing levonorgestrel at least six months ago, and prospectively Short form 36 (P-36); It covers the comparison of the Quality of Life Scale and the Female Sexual Function Scale (FSFI) by asking over the phone.

NCT ID: NCT05299801 Active, not recruiting - Clinical trials for Abnormal Uterine Bleeding

DAta MIning to Evaluate Novasure Treatment

DAMIEN
Start date: July 1, 2021
Phase:
Study type: Observational

Abnormal Uterine Bleeding (AUB) is a common health problem that affects approximately 30% of women of reproductive age and can have several underlying causes. It significantly affects quality of life, use of medical resources and health costs. Endometrial ablation is a commonly used minimally invasive surgical procedure for the treatment of AUB that destroys endometrial tissue. This procedure is an alternative treatment to hysterectomy because it is less invasive and has a shorter recovery period. Several ablation techniques are available to remove endometrial tissue, including bipolar radiofrequency (NovaSure treatment). While patient satisfaction with this form of endometrial ablation for the treatment of AUB is high, approximately 10-20% of women undergoing endometrial ablation require additional invasive surgery, primarily because of persistent blood loss or pain. There is therefore a need to identify and evaluate factors that can improve women's outcomes, or that can be building blocks for prognostic models that can be used to influence clinical practice. In this 10-year single-center retrospective cohort study, we aim to apply data mining and machine learning techniques to uncover hidden relationships/patterns between variables, and identify factors and patients at increased risk for Novasure treatment failure. With multiple time variables, this is not possible with a simple statistical analysis. Discovering these patterns and risk factors could help improve medical care, patient counseling and patient satisfaction.

NCT ID: NCT04434066 Active, not recruiting - Surgery Clinical Trials

Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy

Start date: January 8, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate differences in perioperative and postoperative outcomes between the abdominal (AM) versus vaginal (VM) routes of contained morcellation in participants undergoing laparoscopic total hysterectomies in a randomized controlled trial.

NCT ID: NCT02002260 Active, not recruiting - Clinical trials for Abnormal Uterine Bleeding

Stopping Heavy Periods Project

SHiPP
Start date: February 2013
Phase: N/A
Study type: Interventional

This study is a randomized clinical trial comparing the effectiveness of the levonorgestrel intrauterine system (LNG-IUS) to combined oral contraceptives (COCs) for improving quality of life among women who report heavy menstrual bleeding.